The effects of reducing stress on blood pressure were investigated in 20 patients with non-insulin-dependent diabetes mellitus. An anxiolytic, fludiazepam, was administered to the patients for 12 weeks and their blood pressures and State Trait Anxiety Inventory scores at the beginning and end of treatment were compared. Systolic and diastolic blood pressures and trait and state anxiety scores were all significantly reduced during the treatment period. There was also a weak correlation between the extent of the improvement in the same anxiety score and the improvement in diastolic blood pressures.
SurwitRSFeinglosMNStress and autonomic nervous system in type II diabetes: a hypothesis. Diabetes Care1988; 11: 83–85.
2.
FullerJHStevensLKEpidemiology of hypertension in diabetic patients and implications for treatment. Diabetes Care1991; 14: 8–12.
3.
MogensenCEHansenKWNielsenSMonitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease – reproducibility, progression and efficacy of antihypertensive intervention. Am J Kidney Dis1993; 22: 174–187.
4.
WHO Study Group on Diabetes Mellitus: Report of the WHO Expert Committee on Diabetes Mellitus, Report No. 727, WHO Technical Report Series. Geneva, 1985.
5.
SpielbergerCDGorsuchRCLusheneRFManual for the State-Trait Anxiety Inventory.Palo Alto, California: Consulting Psychologists Press, 1970.
6.
KatsuraTClinical evaluation of Erispan® (fludiazepam) on vegetative dystonia. The Clinical Report1989; 23: 353–366.
7.
HunyorSNBartropRCraigAVoluntary blood pressure control by biofeedback: relationship to psychological characteristics. Clin Exp Pharmacol Physiol1991; 18: 55–59.
